Axis Securities Upgrades Apcotex Industries to BUY

• Revenue: Rs 499 Cr
• PAT: Rs 35 Cr

Reader Takeaway: Analysts favor long-term expansion potential despite current margin compression caused by nitrile latex global oversupply issues.

What just happened

Axis Securities has upgraded its rating for Apcotex Industries from HOLD to BUY, setting a target price of Rs 650. This decision follows a Q2FY27 performance where the company missed analyst estimates for revenue, EBITDA, and PAT. Revenue for the quarter stood at Rs 499 Cr, marking a 48% YoY increase but a 5% decline on a sequential basis. The company reported a PAT of Rs 35 Cr.

Why this matters

The brokerage move highlights a shift in focus from immediate quarterly volatility to the company's long-term expansion narrative. Apcotex is currently investing Rs 210–220 Cr in its Valia facility, which is central to its goal of achieving a 10–12% volume CAGR over the next 3–5 years. Investors are closely watching the commissioning timelines, with NBR expansion expected by April 2027 and SBR latex expansion by Q2FY28.

Risks to watch

Margin pressure remains a significant concern. Nitrile latex margins saw a sharp normalization in Q2FY27 following elevated levels in the previous quarter, largely due to post-COVID global overcapacity. Additionally, the company is managing high working capital requirements, with inventory and trade receivables standing at Rs 172 Cr and Rs 321 Cr, respectively. Other risks include potential shifts in anti-dumping duties and geopolitical instability affecting exports.

What to track next

Key milestones include the progress of the Valia facility expansion and the company's ability to maintain margin stability. The company's pivot toward high-margin niche products—such as battery binder latex, bio-based polymers, and specialized oil-drilling chemicals—will be critical in offsetting competitive pressures in the broader latex market.